NCT00761514View on ClinicalTrials.gov

Evaluation of Quality of Life Changes in Puerto Rican Subjects With Active Rheumatoid Arthritis Treated With Humira

PHASE4TerminatedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Humira (adalimumab)

40 mg eow

Trial Locations (10)

00602

Aguada

00961

Bayamón

00726

AJP Med, Inc. PSA, Caguas

Caguas

00777

Humacao

00674

Manatí

00923

Rio Piedras

00927

Rio Piedras

00910

San Juan Arthritis & Research Center, San Juan

00918

San Juan

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY

NCT00761514 - Evaluation of Quality of Life Changes in Puerto Rican Subjects With Active Rheumatoid Arthritis Treated With Humira | Biotech Hunter | Biotech Hunter